These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
No trial status on register 2004-005207-15 Low dose muscle relaxant in intubation in children bad-data
Not reported 2005-000496-17 Atorvastatin in moderat active Crohns disease 2007-09-04 due-trials
Completed, but no date Terminated 2008-000306-36 Nexavar in Relapsed Peripheral T-cell Non-Hodgkins Lymphoma bad-data
Not reported 2008-001871-31 Local steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment 2021-10-01 due-trials
Ongoing 2010-018604-85 Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant not-yet-due
Ongoing 2011-001264-22 Eplerenone and spironolactone in male patients with ascites due to liver cirrhosis. A Swedish prospective randomized multicenter study of efficacy and endocrinologic side effects. Eplerenon versus ... not-yet-due
Completed, but no date 2013-004224-10 Prospective randomized trial comparing the effects of oxytocin and carbetocin on circulation and vascular tone at cesarean section Prospektiv randomiserad studie jämförande effekter av oxytocin oc... bad-data
Ongoing 2015-002506-37 Dexmedetomidine for analgosedation to newborn infants during neonatal intensive care – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study.Cohort 3 in The SANNI Project... not-yet-due
Ongoing 2016-000235-40 Stopping anti-TNF treatment in Crohn’s and Colitis patients in remission Utsättning av anti-TNF terapi hos patienter med ulcerös kolit eller Crohns sjukdom i lugn fas not-yet-due
Not reported 2016-004120-39 An experimental pilot study on immune and inflammatory biomarkers in patients with advanced prostatecancer treated with degarelix vs. GnRH agonist and with cardiovascular disease 2022-06-22 due-trials
Ongoing 2017-002008-28 A prospective open label study to evaluate treatment of chronic HCV infection with glecaprevir/pibrentasvir in PWID attending a needle exchange program not-yet-due
Not reported 2018-004205-12 Methylprednisolone injection in treatment of birch pollen induced allergic rhinitis 2019-05-31 due-trials
Reported results 2019-001907-19 Pramipexole augmentation to target anhedonia in depression - a pilot study Tilläggsbehandling med Pramipexol mot anhedonisymptom vid depression - en pilotstudie 2021-03-18 due-trials
Completed, but no date, and reported results Terminated 2019-002226-79 A 30-day, randomized, evalUator-blind, controlled, multi-centre, parallel Group, phase III study to evaluate the Effect of a Low Maintenance Dose TicAgrelor Regimen versus Standard Dose Clopidogrel on... bad-data
Ongoing 2019-002361-35 Intavenous Lidocain and postoperative recovery after liver surgery- a randomized double blinded trial Intravenöst Lidokain och postoperativ återhämtning efter leverkirurgi, en randomiserad dubbelbl... not-yet-due
Ongoing 2020-001728-33 Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial) Adjuvant instillation med gemcitabin eller mitomycin efter TURB för intermediärrisk ick... not-yet-due
Not reported 2020-001849-39 Aerosolized DNase I for the treatment of severe respiratory failure in COVID-19 - a phase 2, randomized controlled trial 2023-01-10 due-trials
Ongoing 2020-002433-15 Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948 not-yet-due
Ongoing 2020-005738-13 Pivmecillinam with Amoxicillin/clavulanic acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales. not-yet-due
Ongoing 2021-000413-17 COVERS (COVID-Vaccination Efficiency Risk and Safety Study) - an open trial for follow-up of efficacy, risk and safety in persons who have been vaccinated against SARS-CoV-2 in Region Skåne with vacci... not-yet-due
Exempt 2021-001366-38 STEM-PD trial: A multicentre, single arm, first in human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell derived dopami... not-yet-due
Ongoing 2021-002218-15 Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors - An open-label, multicenter, randomized controlled trial comparing safety and efficacy of personalized vs non-personalized radionuclid... not-yet-due
Ongoing 2021-003755-41 ERIS- EGFR-Mutated Lung Cancer in Randomized Investigator-Initiated Study not-yet-due
Ongoing 2022-001563-26 Pramipexole for Anhedonic Depression (PRIME-PRAXOL) Tilläggsbehandling med Pramipexol mot Anhedonisymptom vid Depression - PRIME-PRAXOL not-yet-due